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ABSTRACT Evidence for a mechanism of initiation of
viral persistence in which the cell, and not the virus, plays a
critical role has been obtained using the important animal
pathogen foot-and-mouth disease virus (FMDV). We have
developed a virulence assay consisting of quantification of the
ability of virus to kill cells and of cells to divide in the presence
of virus and to initiate a carrier state. Cells were cured of
FMDV at early times following a cytolytic infection ofBHK-21
monolayers with FMDV. When cured cells were subjected to
the virulence assay they showed an increased ability to survive
a second infection by FMDV but not by other RNA viruses.
This altered phenotype was maintained as a stable genetic trait.
When the virus present in such early surviving cells was used
to infect BHK-21 cells, It proved to be as virulent as the initial
cytolytic FMDV and, furthermore, its ability to kill BHK-21
cells increased upon replication in the surviving cells. Both the
level ofgenetic heterogeneity and the rate ofevolution ofFMDV
were similar to those previously documented during acute and
persistent FMDV infections. The results suggest that, in con-
trast to most other viral systems, the critical element in the
establishment of a persistent infection of BHK-21 cells with
FMDV is the ability of the host cells to vary genetically and
phenotypically, which promotes selection of cells with in-
creased resistance to virus. The possible relevance of this
mechanism to viral persistence in vivo is discussed.
Viruses that are normally lytic for cells can occasionally
diverge from this behavior and establish persistent infections
in their host organisms or in cultured cells. Persistence of
viruses cannot be attributed to a single mechanism since
several genetic features ofboth the virus and the host cells or
organisms have been implicated in long-term survival of
infected cells (1-5).
Picornaviruses are no exception to such a dual behavior of
either killing cells or surviving with them (6-8). Persistent
infections in cell culture have been described for most
picornaviruses, including Theiler's murine encephalomyelitis
virus (TMEV) (9), poliovirus (10-12), rhinovirus (13), hepa-
titis A virus (14), echovirus (15), and foot-and-mouth disease
virus (FMDV) (16, 17). Persistent infections of cloned
BHK-21 cells with clonedFMDV C-S8cl were established by
growing the cells that survived a cytolytic infection (16).
Following the establishment of persistence, and upon serial
passage of the carrier cells, the resident FMDV became
progressively more virulent for BHK-21 cells than its paren-
tal FMDV C-S8cl. The carrier cells, in turn, evolved to
become increasingly resistant to FMDV but not to other
RNA viruses, suggesting a coevolution of the cells and of
their resident virus (17, 18).
An important role of the host cell in maintenance of a
persistent infection in cell culture has been previously doc-
umented for reovirus (19, 20) and poliovirus (21, 22), but a
role of cell variation in the initiation of persistence has not
been established. Here we report experiments aimed at
defining the critical element in the initiation of a viral per-
sistent infection. The results indicate that BHK-21 cells, and,
more specifically, their ability to vary genetically, are the
determinant element in initiating FMDV persistence. This
was surprising in view of the well-documented genetic het-
erogeneity and phenotypic flexibility of RNA virus quasi-
species (23-25) and the accumulated evidence that in most
other systems either the down-regulation of viral functions or
the expression of specific viral genes is the main contributor
to limiting cell killing (3). We show that FMDV genomic
sequences fluctuate at the onset of persistence but that the
virus adapts to the first surviving cells by selecting more
virulent-rather than attenuated-variants. These results
provide evidence of a mechanism of initiation of viral per-
sistence in which the cell, and not the virus, plays the critical
role.
MATERIALS AND METHODS
Cells, Viruses, and Infections. The origin of cloned BHK-
21cl cells, ofplaque-purified FMDV C-S8cl, and procedures
for cell growth, subcloning of cells by end-point dilution,
infection of BHK-21 cell monolayers, release of intracellular
virus by freeze-thawing of a cell suspension followed by
sonication, and plaque assays with FMDV have been de-
scribed (16, 17).
Treatment of Cells with Ribavirin and Aphidicolin. Cells
were cured of FMDV by treatment with the cytostatic
nucleoside analogue ribavirin (1-/3-D-ribofuranosyl-1-H-1,2,4
triazole-3-carboxamide) (26) as described (27). Curing of cells
was routinely monitored by the absence ofinfectious FMDV,
by negative hybridization to a labeled oligonucleotide probe
(17), or by reverse transcription and PCR amplification using
primers corresponding to essential regions of the genome
(limit of detection, 0.02 FMDV genome per cell; A.M.M.H.,
unpublished results). To inhibit cell division during infection
of BHK-21 cells with FMDV, the cells were pretreated for 6
hr and throughout the infection with aphidicolin (tetradeca-
hydro-3,9-dihydroxy-4,llb-dimethyl-8,lla-methano-lla-H-
cyclohepta[a]naphthalene-4,9-dimethanol), a specific inhibi-
tor of cellular DNA polymerase a (28). The cytostatic and
cytotoxic actions of ribavirin, aphidicolin, or mixtures of the
two drugs were analyzed under our culture conditions of
BHK-21 cells by determining the number of viable and
nonviable cells by trypan blue staining (data not shown). At
the concentration used (5 zg/ml), aphidicolin caused a 50%o
inhibition of FMDV production by BHK-21 cells.
Abbreviations: ATCC, American Type Culture Collection; p.i.,
postinfection; FMDV, foot-and-mouth disease virus; IRES, internal
ribosome entry site; pfu, plaque-forming unit(s); TMEV, Theiler's
murine encephalomyelitis virus.
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Table 1. Frequency of cell survivors upon infection of cloned
and uncloned BHK-21 cell populations with FMDV
Cells Frequency of survivors
BHK-21c1 (1.6 ± 1.1) x 10-3
Subclone B12 (8.1 ± 0.5) x 1 4
Subclone A5 (1.2 ± 0.2) x 1 f3
Subclone H4 (1.8 ± 0.5) x 10-3
BHK-21 ATCC (1.0 ± 0.3) x 10-3
Cl-BHK-Rclp86-Rbv (cured) (3.3 ± 0.4) x 10-1
Monolayers of 2-4 x 106 cells were subjected to the virulence
assay by infecting with FMDV C-S8cl. The frequency of cell
survivors (mean ± SD) was determined as detailed in the text.
Subclones B12, A5, and H4 were derived from our cloned stock
BHK-21c1 (17) by isolation of single cells by end-point dilution and
growth of single cells to the minimum extent required for freezing and
for use in the virulence assay (about 107 cells). BHK-21 ATCC were
received from the American Type Culture Collection and used
without cloning. Cl-BHK-Rclp86-Rbv are BHK-21 cells persistently
infected with FMDV C-S8c1 passaged 86 times and then cured of
FMDV by ribavirin treatment (17).
Virulence Assay. The susceptibility of cells to killing by
FMDV and the ability ofFMDV to kill cells were quantitated
by a virulence assay as follows. The cells to be tested were
grown until they formed a complete cell monolayer and then
were infected with FMDV C-S8cl at a multiplicity of infec-
tion of0.1 plaque-forming unit (pfu) per cell. This multiplicity
of infection was chosen to minimize the possible accumula-
tion of defective interfering RNAs in infected cells. Under
these conditions, overt cytopathic effect was seen at 12-24 hr
postinfection (p.i.). Then, at 48 hr p.i. the medium was
withdrawn and the surviving cells were washed and either
fixed (10%o formaldehyde), stained (2% crystal violet in 10%
formaldehyde), and counted directly under a grid or main-
tained in culture medium for 3-4 days until surviving cells
formed small colonies. Then, the colonies were fixed,
stained, and compared with dishes containing known num-
bers of cell colonies. Standard calibration plates consisted of
eight triplicate series of plates with 102 up to 106 cells per dish
grown for 4 days. To test the virus shed by cells without the
virus undergoing any amplification, virulence assays had to
be frequently performed at multiplicities of infection as low
as 10-4 pfu per cell, including the reference virus C-S8cl. No
significant effect of the multiplicity of infection on the fre-
quency of cell survivors has been seen over the range of 10-4
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FIG. 1. Virulence of FMDV replicating in cells that survived a
cytolytic infection. Monolayers of BHK-21cl cells were infected
with FMDV C-S8cl as indicated in the legend to Table 1. When the
cytopathic effect was complete, the surviving cells were washed
extensively and maintained in culture. Virus from the culture me-
dium was isolated at the indicated times p.i. and subjected to the
virulence assay. The results (mean ± SD) expressed as frequency of
surviving cells are the average of at least three determinations. The
virulence of the progeny FMDV C-S8cl from the initial cytolytic
infection was (1.6 ± 1.1) x 10-3 (average of 22 determinations,
arrow).
to 10 pfu per cell (ref. 16; unpublished results). All assays
were carried out at least in triplicate, always including
BHK-21cl cell monolayers as reference cells. To test the
virulence of FMDV the assay was as described above using
BHK-21cl cell monolayers as indicator cells and FMDV
C-S8cl as virulence standard.
cDNA Nucleotide Sequencing. The RNA corresponding to
the internal ribosome entry site (IRES) and the leader (L)
protease was amplified by reverse transcription and PCR
using primers 5'-TCGCTTTCGAGTTC-3' (complementary
to FMDV genomic positions 1322-1307) and 5'-CACGAG-
CTAAGCAGGTTTCC-3' (corresponding to nucleotides
246-265 of the genomic RNA) as described (29).
RESULTS
Cells That Survive a Cytolytic Infection by FMDV Show a
Rapid Increase of Resistance to the Virus. The frequency of
cells that survived a cytolytic infection with FMDV C-S8cl
varied from 1 x 10-3 to 3 x 10-4 in different experiments,
independently of using cloned or uncloned BHK-21 cell
populations (Table 1). Carrier cells cured of FMDV after
Table 2. Survival of BHK-21 cells upon infection with FMDV
Frequency of cell survivors
Experiment Cells Treatment upon reinfection with FMDV
1 BHK-21cl None (3.1 ± 0.3) x 10-3
Ribavirin (2.7 ± 0.8) x 10-3
Infected BHK-21cl Ribavirin at 12 hr p.i. (6.9 ± 0.4) x 10-3
Ribavirin at 24 hr p.i. (9.9 ± 0.2) x 10-3
Ribavirin at 48 hr p.i. (9.5 ± 0.4) x 10-3
Ribavirin at 4 days p.i. (1.0 ± 0.1) x 10-2
2 BHK-21 ATCC None (1.1 ± 0.1) x 10-3
Ribavirin (1.0 ± 0.3) x 10-3
Infected BHK-21 ATCC Ribavirin at 48 hr p.i. (2.0 + 0.1) x 10-3
Ribavirin at 60 days p.i. (2.2 ± 0.3) x 10-1
3 BHK-21cl None (3.7 ± 1.0) x 10-4
BHK-21cl infected in the presence of aphidicolin Aphidicolin ribavirin at 36 hr p.i. (8.3 ± 4.9) x 10-4
Aphidicolin ribavirin at 48 hr p.i. (2.7 ± 0.5) x 10-4
Monolayers of 2-4 x 106 BHK-21 cells were either mock-infected or infected with FMDV C-S8cl at a multiplicity of infection of 0.1 pfu per
cell in the absence (experiments 1 and 2) or the presence (experiment 3) of aphidicolin. The infection was allowed to proceed for the indicated
times after infection (p.i.) and then the surviving cells were extensively washed and treated with ribavirin (2 mg/ml for 72 hr) as described (27).
In experiment 3 the cells were not maintained in the presence of aphidicolin for longer than 48 hr p.i. to avoid loss of cell viability. The resulting
cells, cured of any detectable FMDV (see text), were grown to the minimal extent needed for freezing and to form a monolayer (1 x 107 cells).
These monolayers, along with untreated or ribavirin-treated mock-infected cells, were reinfected with FMDV C-S8cl (0.1 pfu per cell) for 48
hr until the cytopathology was complete. Each value (mean ± SD) is the average of at least four determinations.
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prolonged persistence with FMDV showed a 200-fold in-
crease in survival frequency upon infection with FMDV
C-S8cl (Table 1). To establish whether any increase of cell
resistance took place at the time of establishment of persis-
tence, we cured cells at 12 hr to several days p.i. and
subjected the cured cells to the virulence assay (Table 2).
Cells cured as early as 12-48 hr p.i. were 2- to 3-fold more
resistant to FMDV C-S8cl than mock-infected cells sub-
jected to parallel ribavirin treatment.
Basal Cell Resistance Does Not Require Cell Division in the
Presence of Virus. Cells with increased resistance to FMDV
C-S8cl either could preexist in the population or be the result
of the infection and selection by FMDV. To distinguish
between these two possibilities we carried out infections in
the presence of the cytostatic agent aphidicolin (see Mate-
rials and Methods). The results (experiment 3, Table 2)
suggest that when cell division was prevented by maintaining
aphidicolin prior to and during the cytolytic infection, the
resistance ofcured BHK-21cl cells to FMDV C-S8cl was not
significantly different from the resistance manifested by the
parental BHK-21cl cells. The same result was obtained at
multiplicities of 10 pfu per cell in infections carried out in the
presence of aphidicolin (results not shown). Thus, the basal
level of cell resistance seen in any cytolytic infection by
FMDV (16) (Table 1) does not require cell division in the
presence of FMDV.
The basal level and the enhanced resistance of BHK-21
appear to be specific for FMDV since no significant survival
of cells was seen when encephalomyocarditis virus-a picor-
navirus closely related to FMDV-or vesicular stomatitis
virus was used as challenge virus in the virulence assay
(results not shown). Increased resistance of BHK-21 cells to
FMDV appears to be a stable genetic trait since 10 serial cell
passages did not result in any detectable alteration in the
degree of resistance of the cells to the virus.
The Virus That Replicates in the Initial Surviving Cells Is
Not Attenuated and It Rapidly Becomes Hypervirulent for
BHK-21 Cells. To test whether the virus that replicated within
the surviving cells at the beginning of persistence was atten-
uated for BHK-21 cells, we subjected virus shed by carrier
cells-at 1-20 days after the initial cytolytic infection, with-
out any amplification-to the virulence assay. The results
(Fig. 1) indicate that the virulence of the virus isolated during
the first 10 days was either indistinguishable from or higher
than the virulence of the parental FMDV C-S8cl. After day
10, sequential viral samples revealed a dramatic increase in
virulence, with <10-5 frequency of surviving cells in infec-
tions with the virus rescued at day 20 (Fig. 1).
This result did not exclude that the virus that remained
inside the surviving cells (rather than being shed from the
cells) could constitute a distinct subpopulation with de-
creased ability to kill cells. To test this possibility, the cells
that had survived the cytolytic infection were lysed and the
liberated virus, without any further amplification, was sub-
jected to the virulence assay. The intracellular virus and the
virus shed into the medium during the first 3 hr immediately
following cytopathology were indistinguishable from their
parental FMDV C-S8cl with regard to virulence for BHK-21
cells (Table 3). It was still possible that, in spite of the virus
being fully virulent, some defective interfering viral RNA
could be present that contributed to limiting cell killing. No
interference activities were present in the culture medium or
in the RNA from cells that showed increased resistance to
FMDV (results not shown). We conclude that the virus able
to survive a cytolytic infection of BHK-21 cells is not
attenuated for these cells and that it rapidly becomes hyper-
virulent relative to its parental FMDV C-S8cl.
The FMDV Quasispecies During the Establishment of Per-
sistence Shows Rapid Evolution and a High Level of Genetic
Heterogeneity. The above results suggest that the determinant
element in the initiation of a persistent FMDV infection is not
the virus but the ability of BHK-21 cells to vary upon growth
from a single cell to provide phenotypes with a slightly
increased resistance to FMDV. This was surprising in view
of the extensive genetic and phenotypic heterogeneity of
FMDV populations documented in vivo as well as in cell
culture (30). It was possible, however, that the virus that
survived in early cells might be unusually homogeneous, thus
explaining its inability to provide components of the mutant
spectrum with reduced ability to kill cells. To sample the
extent of genetic heterogeneity and variation of FMDV
during the establishment of persistence we sequenced the
IRES (an essential element for initiation of translation) and
the RNA region encoding the L protease (an essential protein
for polyprotein processing and for cleavage of the p220
component of the cap-binding complex) of sequential virus
samples from the early surviving cells. The rate of fixation of
mutations was 4 x 10o- to 6 x 10-5 substitutions per
nucleotide per day and the mutant frequency ranged between
1.6 x 10-3 and 1.6 x 10-4 substitutions per nucleotide (Fig.
2). None of these values is lower than previously determined
for other evolving FMDV populations (30). Remarkably, in
each of the four viral populations analyzed, a silent mutation
in the L-coding region (A-1159 -- G) became dominant.
Repeated silent mutations in coding regions have been re-
cently described during poliovirus persistence (12). The
possible significance of this silent replacement in early stages
of FMDV persistence is not known.
DISCUSSION
Mechanism of Initiation of Viral Persistence. A role of the
host cell in maintenance of viral persistence has been docu-
mented for several systems (17, 19-22, 31, 32). In the present
report we have provided evidence of an essential role of the
host cell at the crucial step of initiation of viral persistence.
Table 3. Virulence of intracellular and extracellular virus that replicated in surviving cells at the onset of
FMDV persistence
Frequency of cell survivors upon
Virus infection of BHK-21c1 cells
FMDV C-S8c1 (2.6 ± 0.2) x 10-3
Extracellular, collected within 3 hr after the peak of cytopathology (2.1 ± 0.3) x 10-3
Intracellular, from surviving cells lysed at 3 hr after the peak of cytopathology (1.5 ± 0.2) X 10-3
BHK-21c2 cell monolayers (1-2 x 107 cells in each of twenty 100-mm Petri dishes) were infected with FMDV C-S8cl.
At 36 hr p.i. the cytopathic effect was complete and the surviving cells were washed 20 times with 5 ml of culture medium.
Aliquots of the medium from the last washing were titrated. The surviving cells (about 104 per infected monolayer) were
incubated with culture medium (500 p1 per Petri dish) for 3 hr at 370C. The total number of pfu shed by the cells during this
period was 3 x 104 pfu (the last washing of cells included 5% of this amount). Then the cells were washed, collected,
resuspended in 0.5 ml of phosphate-buffered saline, and lysed by three cycles of freezing and thawing and sonication. The
pfu recovered from lysed cells was 2 x 104. Extracellular and intracellular viruses were used in the virulence assay without
prior amplification, as detailed in the text. The results (mean ± SD) are the average of four determinations.
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FIG. 2. Temporal evolution of the FMDV quasispecies during the establishment of a persistent infection. (A) Scheme of the FMDV genome
and location of the 5' untranslated region and L protease-coding region sequenced in the present study. The sequence for FMDV C-S8c1 has
been previously reported by Escarmfs et al. (ref. 29; unpublished data). Numbering of residues is according to ref. 29, counting as number 1
the first nucleotide to the 3' side ofthe polyribocytidylate tract (Cn). The arrow indicates the beginning ofthe IRES element. The dots at positions
6% and 699 were introduced to align the FMDV C-S8cl sequence with that of other FMDV strains (29). The two initiation codons that direct
synthesis oftwo forms ofL are underlined. (B) Summary ofnucleotide sequence comparisons ofthe IRES and L-coding region ofFMDV during
four independent events of establishment of persistence ofBHK-21cl cells with cloned FMDV C-S8cl (experiments 1-4). In experiments 1 and
2, only average sequences at the indicated days p.i. (dpi) were analyzed. Average sequences are depicted as lines on which only those residues
that vary relative to the C-S8c1 sequence (top line) are indicated. In experiments 3 and 4, in addition to average sequences, individual molecular
clones were also sequenced from pUC19 recombinants (box below the corresponding average sequence); in each case 10 clones were sequenced,
except for the samples at 30 and 36 dpi, experiment 3, for which 13 and 14 clones, respectively, were analyzed; the percentage of clones with
a nucleotide sequence is given in each box. The total number of residues screened was 46,490. It cannot be excluded that the six substitutions
found only once in the clonal analyses could result from misincorporations during reverse transcription or Taq amplification; elimination ofthese
unique replacements from the calculations decreased only the estimated levels of heterogeneity of population 25 dpi, experiment 3, by a factor
3.5 (see text). The silent replacement A-1159 -- G was not found in any of six samples of FMDV C-S8cl passaged 2, 6, and 10 times in lytic
infections of BHK-21 cells (results not shown).
B
Proc. Natl. Acad. Sci. USA 91 (1994) 3709
The small increase in resistance seen in cells cured at 12 hr
to 4 days p.i. (Table 2, experiment 1) could result from the
clonal expansion of the variant cells present in any clonal
BHK-21 population (Table 1) freed from fully susceptible
cells in the first infection. However, the small increase could
also be the result of additional cell variation and further
selection by FMDV, a process that becomes apparent when
cells that survive cytolysis are allowed to grow for prolonged
periods of time prior to curing (Table 1, C1-BHK-RC1p$6-
Rbv cells, and Table 2, experiment 2). Irrespective of the
selection by FMDV being exerted during or immediately
following a cytolytic infection, the essential feature that
determined cell survival was the ability of the cells to vary
genetically in the course of growth from a single cell to a
monolayer (Tables 1 and 2). Generation of cell diversity may
be favored by a certain degree of cellular transformation-
with its inherent general genetic instability (33)-docu-
mented for established cell lines, thus providing BHK-21
cells with an expanded range of phenotypes. Additional
genetic lesions in the cells could also be induced by the
replication of FMDV by an as yet unidentified mechanism.
The possibility that cell variation could contribute to
initiation of viral persistence in multicellular organisms must
be considered since cell heterogeneity has been described for
normal tissues (34, 35). Even though observations in cell
culture may not necessarily apply to entire organisms, it must
be considered that epithelial cells-the target of FMDV
infection-divide and are replaced at considerable rates.
Thus, cell variation could also play a role in the initiation of
viral persistence in rapidly dividing cells in vivo.
Were Previously Observed Phenotypic Alterations ofViruses
Essential for Initiation of Persistence? The FMDV replicating
in the initially surviving cells was not only fully virulent, but
it showed neither a ts character nor a small-plaque phenotype
(results not shown), traits that become dominant at later
stages ofpersistence (16). These results with FMDV pose the
question of whether in other host-virus systems the genetic
lesions frequently observed in the persistent virus were
essential for initiation of persistence (3) or were a conse-
quence of the optimization of virus to survive in carrier cells
once persistence had already been initiated by other mech-
anisms. It is clear from our results that the quasispecies
structure and consequent adaptability of RNA genomes
(23-25, 30) do not justify any generalization on the partici-
pation of viral quasispecies, rather than the seemingly more
static cellular DNA genomes, in initiation of viral persis-
tence.
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